Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection

Petrovic Fabijan, Aleksandra; Lin, Ruby C. Y.; Ho, Josephine; Maddocks, Susan; Ben Zakour, Nouri L.; Iredell, Jonathan R.

doi:10.1038/s41564-020-0698-9

Download PDF

Publisher Correction
Published: 05 March 2020

Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection

Aleksandra Petrovic Fabijan ORCID: orcid.org/0000-0003-3172-2375^1,2^na2,
Ruby C. Y. Lin ORCID: orcid.org/0000-0003-4163-511X^1,2,3,4^na2,
Josephine Ho^1,2,
Susan Maddocks^1,2,3,
Nouri L. Ben Zakour^1,3,
Jonathan R. Iredell ORCID: orcid.org/0000-0003-2469-7060^1,2,3 &
Westmead Bacteriophage Therapy Team

Nature Microbiology volume 5, page 652 (2020)Cite this article

2224 Accesses
9 Citations
1 Altmetric
Metrics details

Subjects

The Original Article was published on 17 February 2020

Correction to: Nature Microbiology, https://doi.org/10.1038/s41564-019-0634-z, published online 17 February 2020

In the version of the Article originally published, the following text was mistakenly omitted from the end of the abstract: “Trial Registration: Westmead Hospital Human Research Ethics Committee HREC/17/WMEAD/275; ClinicalTrials.gov: NCT03395769; Clinical Trials Notification (Australian Therapeutic Goods Association): CT-2018-CTN-02372-1.” This has now been corrected.

Author information

A full list of authors and their affiliations appears at the end of the paper.
These authors contributed equally: R. C. Y. Lin and A. Petrovic Fabijan.

Authors and Affiliations

Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
Aleksandra Petrovic Fabijan, Ruby C. Y. Lin, Josephine Ho, Susan Maddocks, Nouri L. Ben Zakour, Jonathan R. Iredell, Ali Khalid & Carola Venturini
Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia
Aleksandra Petrovic Fabijan, Ruby C. Y. Lin, Josephine Ho, Susan Maddocks, Jonathan R. Iredell, Indy Sandaradura & Tim Gilbey
School of Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
Ruby C. Y. Lin, Susan Maddocks, Nouri L. Ben Zakour, Jonathan R. Iredell, Ali Khalid, Carola Venturini, Richard Chard & Indy Sandaradura
School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia
Ruby C. Y. Lin
Department of Cardiothoracic Surgery, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia
Richard Chard
AmpliPhi BioSciences Corporations, Sydney, New South Wales, Australia
Sandra Morales

Authors

Aleksandra Petrovic Fabijan
View author publications
You can also search for this author in PubMed Google Scholar
Ruby C. Y. Lin
View author publications
You can also search for this author in PubMed Google Scholar
Josephine Ho
View author publications
You can also search for this author in PubMed Google Scholar
Susan Maddocks
View author publications
You can also search for this author in PubMed Google Scholar
Nouri L. Ben Zakour
View author publications
You can also search for this author in PubMed Google Scholar
Jonathan R. Iredell
View author publications
You can also search for this author in PubMed Google Scholar

Consortia

Westmead Bacteriophage Therapy Team

Ali Khalid
, Carola Venturini
, Richard Chard
, Sandra Morales
, Indy Sandaradura
& Tim Gilbey

Corresponding author

Correspondence to Jonathan R. Iredell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petrovic Fabijan, A., Lin, R.C.Y., Ho, J. et al. Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol 5, 652 (2020). https://doi.org/10.1038/s41564-020-0698-9

Download citation

Published: 05 March 2020
Issue Date: April 2020
DOI: https://doi.org/10.1038/s41564-020-0698-9

This article is cited by

Characterization of Brazilian green propolis as a photosensitizer for LED light-induced antimicrobial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)
- Israel Souza Ribeiro
- Igor Pereira Ribeiro Muniz
- Robson Amaro Augusto da Silva
Photochemical & Photobiological Sciences (2023)

Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection

Subjects

Author information

Authors and Affiliations

Consortia

Westmead Bacteriophage Therapy Team

Corresponding author

Rights and permissions

About this article

Cite this article

This article is cited by

Characterization of Brazilian green propolis as a photosensitizer for LED light-induced antimicrobial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)

Search

Quick links

Subjects

Author information

Authors and Affiliations

Consortia

Westmead Bacteriophage Therapy Team

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

This article is cited by

Characterization of Brazilian green propolis as a photosensitizer for LED light-induced antimicrobial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)

Search

Quick links